Drawing for COOLEST PRODUCT IN MEDICINE

USPTO serial 75912082

COOLEST PRODUCT IN MEDICINE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SMITH, BRIDGETT G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COOLEST PRODUCT IN MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark D. Wieczorek

Mark D. Wieczorek Mayer & Williams251 North Avenue WestWestfield, NJ 07090UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical device, namely, therapeutic device for changing the temperature of bloodACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 2, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 27, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 19, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2003MAILPAPER RECEIVED—
Oct 27, 2003MAILPAPER RECEIVED—
Aug 15, 2003EX5GSOU EXTENSION 5 GRANTED—
Aug 4, 2003EXT5SOU EXTENSION 5 FILED—
Aug 4, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2003EX4GSOU EXTENSION 4 GRANTED—
Feb 11, 2003EXT4SOU EXTENSION 4 FILED—
Feb 11, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 16, 2002EX3GSOU EXTENSION 3 GRANTED—
Aug 9, 2002EXT3SOU EXTENSION 3 FILED—
Aug 9, 2002EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 8, 2002EX2GSOU EXTENSION 2 GRANTED—
Feb 25, 2002EXT2SOU EXTENSION 2 FILED—
Aug 13, 2001EX1GSOU EXTENSION 1 GRANTED—
Aug 7, 2001EXT1SOU EXTENSION 1 FILED—
Feb 27, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 5, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 3, 2000NPUBNOTICE OF PUBLICATION—
Jul 21, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 27, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance